Sophia Genetics Gets CE-IVD Mark for Genetic Tests | GenomeWeb

NEW YORK (GenomeWeb) – Sophia Genetics today said that it has received the CE-IVD mark for genetic testing of familial Mediterranean fever and hypercholesterolemia, enabling the tests to be offered in the European Union and other nations that accept the CE mark for marketing.

The tests are based on next-generation sequencing data and employ the Lausanne, Switzerland-based firm's NGS bioinformatics pipeline.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.